Ani Pharmaceuticals reported $286.52M in Debt for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Ani Pharmaceuticals ANIP:US USD 286.52M 213K
Aurora Cannabis Inc ACB:CN CAD 226.08M 99.49M
Canopy Growth Corp WEED:CN CAD 1.32B 158.19M
Emergent Biosolutions EBS:US USD 1.41B 352.5M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.09B
Heron Therapeutics HRTX:US USD 149.23M 52K
Hikma Pharmaceutical HIK:LN USD 1.28B 268M
Knight Therapeutics Inc GUD:CN CAD 39.06M 849K
Lannett LCI:US USD 623.86M 4.51M
Novartis NVS:US USD 27.91B 530M
Perrigo Ordinary Shares PRGO:US USD 4.11B 4.4M
Teva Pharmaceutical TEVA:IT USD 21.21B 54M
Teva Pharmaceutical Industries TEVA:US USD 21.21B 54M